AMGN - AMGEN INC
329.82
-16.430 -4.982%
Share volume: 3,821,061
Last Updated: 05-01-2026
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
0.37%
PREVIOUS CLOSE
CHG
CHG%
$346.25
-16.43
-0.05%
View ratios
| Fiscal Date | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | 12-31-2025 | 03-31-2026 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | |
| Report Date | 08-06-2024 | 10-30-2024 | 02-14-2025 | 05-01-2025 | 08-05-2025 | 11-04-2025 | 02-13-2026 | 04-30-2026 | |
| Assets | |||||||||
| Total Assets | 90.907 B | 90.883 B | 91.839 B | 89.367 B | 87.897 B | 90.141 B | 90.586 B | 92.504 B | |
| Current Assets | 27.206 B | 26.766 B | 29.030 B | 26.929 B | 26.734 B | 27.885 B | 29.057 B | 31.475 B | |
| Inventories | 7.995 B | 7.362 B | 6.998 B | 6.729 B | 6.583 B | 6.346 B | 6.225 B | 6.186 B | |
| Other Current Assets | 2.976 B | 3.076 B | 3.277 B | 3.258 B | 3.422 B | 3.604 B | 4.133 B | 4.113 B | |
| Short Term Investments | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 9.301 B | 9.011 B | 11.973 B | 8.810 B | 8.028 B | 9.445 B | 9.129 B | 12.038 B | |
| Total Non-current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 6.097 B | 6.156 B | 6.543 B | 6.681 B | 6.855 B | 7.220 B | 7.913 B | 8.216 B | |
| Other Assets | 57.604 B | 57.961 B | 56.266 B | 55.757 B | 54.308 B | 55.036 B | 53.616 B | 52.813 B | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 90.907 B | 90.883 B | 91.839 B | 89.367 B | 87.897 B | 90.141 B | 90.586 B | 92.504 B | |
| Total liabilities | 84.982 B | 83.356 B | 85.962 B | 83.160 B | 80.469 B | 80.522 B | 81.928 B | 83.314 B | |
| Total current liabilities | 21.517 B | 20.312 B | 23.099 B | 23.008 B | 20.476 B | 21.791 B | 25.489 B | 24.955 B | |
| Accounts Payable | 2.267 B | 2.147 B | 1.908 B | 2.406 B | 3.010 B | 2.838 B | 2.367 B | 2.935 B | |
| Other liabilities | 2.363 B | 2.199 B | 2.349 B | 2.210 B | 2.336 B | 2.223 B | 2.378 B | 2.365 B | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 57.117 B | 56.854 B | 56.549 B | 54.013 B | 53.760 B | 52.434 B | 50.005 B | 51.886 B | |
| Other liabilities | 2.363 B | 2.199 B | 2.349 B | 2.210 B | 2.336 B | 2.223 B | 2.378 B | 2.365 B | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 5.925 B | 7.527 B | 5.877 B | 6.207 B | 7.428 B | 9.619 B | 8.658 B | 9.190 B | |
| Common stock | 33.204 B | 33.393 B | 33.533 B | 33.578 B | 33.680 B | 33.841 B | 34.023 B | 34.030 B | |
| Retained earnings | -27.124 B | -25.530 B | -27.590 B | -27.140 B | -25.708 B | -23.800 B | -25.107 B | -24.650 B |